The SELECT trial demonstrated a 20% reduction in major adverse cardiovascular events (heart attack, stroke, cardiovascular death) in people with obesity and established cardiovascular disease
Other anomalies observed include visual defects (63%), cardiac defects (51%), constipation (51%), frequent infections (47%), behavioural problems (39%), sleep disturbances (37%), and microcephaly (31%) (Kennedy et al, 2019)
Our dedicated medical team at Dr Fishers Medical Weight Loss Centers is committed to helping patients navigate their weight loss journey with compassion and expertise
Key Words: Anti-tuberculosis drugs, Hepatotoxicity, Acetyl-L-carnitine, Alpha-lipoic acid, Coenzyme Q10 Introduction Tuberculosis (TB) is an important health problem in the world that is one of the top 10 causes of death